HemaSphere (Apr 2023)

5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE

  • B. Andemariam,
  • A. Inati,
  • R. Colombatti,
  • C. Minniti,
  • C. Brown,
  • M. Hottmann,
  • S. Gray,
  • C. Hoppe,
  • M. Davis,
  • P. Yue

DOI
https://doi.org/10.1097/01.HS9.0000928300.84715.89
Journal volume & issue
Vol. 7, no. S1
pp. 23 – 24

Abstract

Read online

No abstracts available.